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Abstract 
To fulfill their multiple roles in organ development and adult tissue homeostasis 
Hedgehog morphogens (HH) act through their receptor Patched (PTCH) on target 
cells. However, HH actions also require HH binding proteins, auxiliary cell surface 
receptors that agonize or antagonize morphogen signaling in a context-dependent 
manner. Here, we discuss recent findings on the LDL receptor-related protein 2 
(LRP2), an exemplary HH binding protein that modulates sonic hedgehog activities in 
stem and progenitor cell niches in embryonic and adult tissues. LRP2 functions are 
crucial for developmental processes in a number of tissues, including the brain, the 
eye, and the heart, and defects in this receptor pathway are the cause of devastating 
congenital diseases in humans.	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Introduction 
Hedgehogs (HH) are morphogens that govern central patterning processes in the 
embryo but that are also essential for homeostasis of adult tissues. In mammals, HH 
encompass three related proteins, called sonic hedgehog (SHH), desert hedgehog 
(DHH), and indian hedgehog (IHH) (Echelard et al., 1993). Their mode of action is 
prototypical for morphogens, being released from a local source and establishing a 
concentration gradient to pattern a target field. In recent years, much has been learned 
about the mechanisms that determine HH gradient formation in tissues involving 
active transport through cell-cell contacts as well as passive diffusion processes 
(Torroja et al., 2005; Dessaud et al., 2008; Roy et al., 2011; Sanders et al., 2013). 
Also, the mechanism of signaling at the primary cilium, the organelle that transduces 
HH cues into target cells, has been defined in molecular detail (see text box 1). Still, 
the complexity of HH activities in embryonic and adult tissues remains puzzling, in 
some instances promoting while in others impeding cell fate decisions. 
  An intriguing twist in understanding the context-dependent modes of 
HH actions came with the identification of HH binding proteins, cell surface proteins 
that act as auxiliary receptors in HH binding and cellular signal reception. The 
structural organization of HH binding proteins is diverse, including 
glycosylphosphatidylinositol (GPI)-anchored molecules, immunoglobulin domain 
containing proteins, as well as endocytic receptors. Jointly with the HH receptors 
Patched (PTCH) 1 and 2, these HH binding proteins are referred to as the HH 
receptorsome. 
  The structural distinctions but also the unique spatial and temporal 
expression patterns of HH binding proteins argue for specific functions in modulation 
of HH signaling. In recent years, findings from animal models as well as from studies 
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in patients have substantiated this notion, identifying important roles for the HH 
receptorsome in balancing morphogen activities. In this review, we will provide an 
overview of the molecular mechanisms of HH co-receptor functions and their 
implications for mammalian development and disease. Specifically, we will focus on 
the LDL receptor-related protein 2 (LRP2), a member of the LDL receptor gene 
family that exemplifies the context-dependent actions of auxiliary HH receptors. 
 
The HH receptorsome 
In mammals, HH proteins control key processes during embryonic development 
including patterning of the limb buds and neural tube (by SHH) (Ericson et al., 1995; 
Zuniga et al., 1999), formation of bone and cartilage (by IHH) (Vortkamp et al., 1996; 
St-Jacques et al., 1999), and development of germ cells (by DHH) (Bitgood et al., 
1996). Consequently, the absence of HH activities results in various congenital 
defects in patients and animal models. This fact is highlighted by the loss of SHH 
signaling resulting in a failure to ventralize the midline of the neural tube and in 
midline formation defects (Chiang et al., 1996). Affected individuals suffer from 
severe craniofacial malformations and from a fusion of the forebrain hemispheres, a 
syndrome known as holoprosencephaly (HPE) (Roessler et al., 1996). Mutations in 
several components of the SHH signaling cascade cause HPE, including defects in the 
genes encoding SHH and PTCH1, or its downstream targets GLI2, SIX3, and ZIC2   
(reviewed in (Roessler and Muenke, 2010)). 
  The signaling properties of HH proteins are explained by the 
interaction with their primary receptor PTCH1 on targeted cells (see text box 1). 
Thus, it came as a surprise when additional cell surface proteins were identified that 
bound HH proteins and affected morphogen activities (Fig. 1). The first HH binding 
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protein to be uncovered was the HH interacting protein (HHIP). HHIP was identified 
by expression cloning approaches aimed to characterize novel components of the HH 
signaling machinery in the mouse limb bud. HHIP is an 80-kDa protein anchored to 
the cell surface by a single membrane-spanning domain. The protein is unique to 
vertebrates and binds all three mammalian HH variants (Chuang and McMahon, 
1999). Loss as well as overexpression of HHIP in mice impact bone and cartilage 
formation, suggesting a major role for HHIP in control of IHH function (Chuang and 
McMahon, 1999; Chuang et al., 2003). HHIP is an antagonist of the HH pathway, 
likely attenuating signaling by sequestration of the morphogen. Thus, its activity 
partially overlaps with that of unliganded PTCH1 (Jeong and McMahon, 2005; Holtz 
et al., 2013). 
  Whereas HHIP acts as an inhibitor of HH signaling, three additional 
HH binding proteins were identified subsequently because of their ability to promote 
SHH signaling. Growth arrest specific protein 1 (GAS1) is a 45-kDa polypeptide 
tethered to the cell surface via a GPI anchor (Stebel et al., 2000). It was retrieved by 
expression cloning of novel SHH binding proteins from cultured cells (Lee et al., 
2001a), and later shown to impair craniofacial and eye development when inactivated 
in mice (Lee et al., 2001b; Martinelli and Fan, 2007). The relevance of GAS1 for 
SHH-dependent forebrain patterning was substantiated by the identification of 
missense mutations in GAS1 in HPE patients. These mutations reduce the affinity of 
the receptor for SHH (Pineda-Alvarez et al., 2012). Additional HH binding proteins, 
that facilitate SHH signaling, are two related receptors of the immunoglobulin super 
family, termed CDON (cell adhesion molecule-related/down regulated by oncogenes) 
and BOC (brother of CDON). In contrast to the vertebrate-specific GAS1, CDON and 
BOC homologues are also found in invertebrates (Lum et al., 2003; Yao et al., 2006; 
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Camp et al., 2010; Zheng et al., 2010). Involvement of CDON in SHH signaling was 
documented by loss of function phenotypes in mice causing holoprosencephalic 
syndrome (Cole and Krauss, 2003; Zhang et al., 2006). Also, mutations in CDON, 
disrupting its ability to interact with PTCH1, have been identified in HPE patients 
(Bae et al., 2011). Inactivation of Boc in mice results in misguidance of commissural 
axons in the spinal cord, a defect in line with the role of SHH as midline derived 
chemoattractant (Okada et al., 2006). Although absence of BOC does not impact 
forebrain development per se, it aggravates the spectrum of forebrain malformation 
when combined with Gas1 (Izzi et al., 2011) or Cdon (Zhang et al., 2011) defects in 
mice.  
  According to current concepts, GAS1, CDON, and BOC directly 
interact with PTCH1 to form high affinity receptor complexes that facilitate signal 
reception under limiting SHH concentrations (as in the developing neural tube). 
Agonistic actions are unique to each of the receptors as judged from the distinct 
phenotypes seen in Cdon, Gas1, and Boc single mutant mice, and by the progressive 
worsening of SHH-related phenotypes when combining individual receptor gene 
defects (Allen et al., 2007; Izzi et al., 2011; Zhang et al., 2011). In fact, the full 
spectrum of phenotypes reminiscent of Shh mutant mice requires elimination of all 
three HH binding proteins (Allen et al., 2011). 
  The latest addition to the HH receptorsome is a 600-kDa cell surface 
protein called LRP2 (also known as megalin). LRP2 is a type-1 transmembrane 
receptor of the LDL receptor gene family, a group of structurally related endocytic 
receptors (see text box 2). LRP2 is expressed in vertebrate and invertebrate species, 
but its role in HH signaling has so far only been confirmed in mammals. As with 
other members of the HH receptorsome, involvement of LRP2 in SHH action has 
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been suggested by HPE-related phenotypes seen in Lrp2 gene-targeted mice (Willnow 
et al., 1996) and in humans with Donnai-Barrow syndrome (DBS), an autosomal 
recessive defect in LRP2 (Kantarci et al., 2007; Kantarci et al., 2008). In the ventral 
neural tube, LRP2 interacts with PTCH1 to promote SHH sequestration and signaling 
during early neurulation (Christ et al., 2012). 
  The identification of several HH binding proteins, seemingly 
performing related functions in promoting SHH signaling during forebrain formation, 
remains puzzling. Yet, recent studies have uncovered unique context-dependent 
functions for GAS1, CDON, BOC, and LRP2 in HH signaling that extend their 
documented roles in forebrain patterning to other organ systems in the embryonic and 
the adult organism, and even encompass functions as agonist or antagonist of the HH 
pathway. In the main part of this article, we will focus on LRP2 as an example of an 
auxiliary HH receptor detailing how it promotes SHH action during forebrain 
development and why familial LRP2 mutations cause forebrain malformation in 
humans. We will discuss possible roles for LRP2 in control of stem cell niches in the 
adult brain and retina, and how receptor dysfunction in these niches alters cell fate 
decisions and may cause cognitive dysfunction and eye disease. We will review new 
findings implicating LRP2 in SHH signaling during heart development, and we will 
present genetic data implicating this receptor in SHH-dependent tumor formation in 
pancreas and prostate. 
 
LRP2, an endocytic receptor directing ligands into different cellular sorting 
pathways 
LRP2 is the phylogenetically most ancient member of the LDL receptor gene family 
conserved from nematodes to man (reviewed in (Christensen and Birn, 2002)). In 
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mammals, the receptor is expressed in specialized absorptive epithelia including 
kidney, lung, reproductive organs, and brain. LRP2 has best been characterized as an 
endocytic receptor in the renal proximal tubules responsible for clearance of low-
molecular weight plasma proteins from the glomerular filtrate. Ligands for LRP2 are 
plasma carriers for vitamins and steroid hormones, such as the vitamin D binding 
protein (DBP) and the retinol binding protein (RBP) (Christensen et al., 1999; 
Nykjaer et al., 1999). Retrieval of carrier proteins in the proximal tubules prevents 
filtration loss of vitamins and hormones bound to these carriers and conserves plasma 
levels of these essential metabolites. Absence of LRP2 in humans and mouse models 
results in loss of plasma proteins into the urine (low-molecular weight proteinuria) 
and in hypovitaminosis (Leheste et al., 1999; Storm et al., 2013). A similar function 
for LRP2 in cellular uptake of androgens and estrogens bound to their carrier, the sex 
hormone binding protein, has been documented in reproductive organs (Hammes et 
al., 2005).  
  A role for LRP2 as clearance receptor for multiple ligands has been 
documented in several epithelia. Remarkably, the fate of ligands internalized by LRP2 
in various tissues is distinct, dependent on the cellular context and the physiological 
needs (Fig. 2). In most instances, ligands internalized from the apical cell surface are 
directed to late endosomal/lysosomal compartments for catabolism (as with DBP and 
RBP). However, some ligands resist lysosomal degradation and move with the 
receptor through the recycling compartments back to the apical cell surface for re-
secretion (e.g., SHH) (Morales et al., 2006). A third route involves ligands trafficked 
by LRP2 from the apical to the basolateral plasma membrane, enabling transcytosis 
through polarized epithelia (e.g., thyroglobin, the carrier for thyroid hormones) 
(Marino et al., 2003). The molecular mechanisms governing different fates for LRP2 
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ligands are poorly understood but likely involve the interaction of the receptor tail 
with cytoplasmic adaptors that sort the receptor into different cellular pathways (Fig. 
2). As detailed below, the ability of LRP2 to direct ligands into different intracellular 
fates may also provide explanatory models for the context-dependent functions of this 
receptor in SHH signaling. 
 
LRP2 promotes SHH activity in neurogenic niches of the developing and adult 
brain 
In the early mouse embryo, expression of LRP2 is restricted to the apical surface of 
the neuroepithelium. Receptor expression in neuroepithelial cells is sustained 
following neurulation and seen most prominent in the ventral domain of the neural 
tube. The relevance of LRP2 for proper specification of the CNS is documented by 
loss of function phenotypes in mouse models with ENU-induced or with targeted 
disruptions of Lrp2 resulting in aberrant dorso-ventral patterning of the neural tube 
and in forebrain formation defects reminiscent of HPE (Willnow et al., 1996; Zarbalis 
et al., 2004; Spoelgen et al., 2005). The identification of LRP2 mutations as cause of 
the autosomal recessive disorder DBS confirmed the relevance of LRP2 for the 
development of forebrain and facial structures in humans (Kantarci et al., 2007; 
Kantarci et al., 2008; Rosenfeld et al., 2010). DBS is a facio-oculo-acoustico-renal 
syndrome that also includes microforms of HPE (Khalifa et al., 2015). All known 
LRP2 mutations affect the extracellular domain of the receptor polypeptide, in most 
instances causing expression of a truncated soluble receptor ectodomain. Genotype-
phenotype correlations are not apparent in these cases. Because of the 
holoprosencephalic features of LRP2- deficient individuals and because of the ability 
of LRP2 to bind SHH in cultured cells (McCarthy and Argraves, 2003), a role for this 
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receptor in SHH action during forebrain development was proposed. This hypothesis 
was substantiated in mouse models of LRP2 deficiency (Christ et al., 2012). In these 
studies, LRP2 was shown to facilitate SHH signaling in the rostral diencephalon 
ventral midline (RDVM), a major forebrain organizer region (Fig. 3A). During 
neurulation, SHH is produced by the prechordal plate (PrCP), a rostral extension of 
the notochord. PrCP-derived SHH moves to the overlying RDVM to pattern this 
target field. In the RDVM, LRP2 forms a co-receptor complex with PTCH1 
facilitating SHH binding and internalization of SHH/PTCH1 complexes, a 
prerequisite for pathway activation (Fig. 3B). The predominant localization of LRP2 
in the ciliary pocket, a cell surface compartment of high endocytic activity, supports a 
role for this receptor in endocytosis of SHH/PTCH1 complexes from the apical cell 
surface (Christ et al., 2012). The necessity of LRP2 for SHH-dependent endocytosis 
of PTCH1 has been extensively documented in cell lines and whole embryo cultures 
(Christ et al., 2012). In contrast, the fate of the receptor ligand remains less clear. 
Because SHH co-localizes with LRP2 to the recycling compartment in neuroepithelial 
cells, SHH molecules internalized by this receptor may be subjected to re-secretion, 
promoting accumulation of the morphogen in its target field (Christ et al., 2012). 
Whether LRP2 may also provide the pathway for initial trafficking of SHH molecules 
from the PrCP to the apical surface of the RDVM remains highly speculative, but the 
ability of LRP2 to mediate epithelial trafficking of SHH has been suggested by 
studies in the epididymis (Morales et al., 2006). 
  Although LRP2 is expressed throughout the entire neural tube, its 
activity in SHH signaling is most relevant for the anterior part of the developing CNS 
(i.e., the forebrain). By contrast, the receptor does not seem to play a crucial role in 
SHH action in the caudal neural tube, as no major patterning defects are seen in the 
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spinal cord of receptor-deficient mice (Wicher and Aldskogius, 2008). Zebrafish 
mutants lacking lrp2 suffer from resorption deficiency of the pronephros but show 
normal forebrain development, arguing that a role of LRP2 in forebrain formation 
may be specific to mammals (Anzenberger et al., 2006; Kur et al., 2011).  
  While the role of LRP2 in HH signaling in other phyla still awaits 
clarification, its relevance for SHH signaling in the mammalian brain likely goes 
beyond forebrain formation. Thus, in the adult brain, expression of LRP2 persists in 
the ependyma, the epithelial cell layer lining the ventricular system. In the lateral 
ventricles, expression of LRP2 is restricted to the lateral wall but not seen in the 
medial wall of the ependyma. This observation is remarkable as ependymal cells of 
the lateral wall face the subventricular zone (SVZ), a neurogenic niche of the adult 
mammalian brain (Merkle and Alvarez-Buylla, 2006; Ninkovic and Gotz, 2007). Loss 
of LRP2 expression in the ependyma results in depletion of neural stem cells and in 
decreased neurogenesis in the SVZ of adult mice (Gajera et al., 2010). Several 
morphogen pathways are implicated in adult neurogenesis in the SVZ, including SHH 
(Ahn and Joyner, 2005; Ihrie and Alvarez-Buylla, 2011). Distinct SHH-responsive 
domains exist in the ventral and in the dorsal SVZ, specifying the formation of 
different subtypes of olfactory bulb interneurons and oligodendroglial cells (Ihrie et 
al., 2011; Tong et al., 2015). Although ependymal cells are not a part of the neural 
stem cell population, they play a vital role in maintaining the microenvironment of the 
SVZ to enable adult neurogenesis (Lim et al., 2000; Colak et al., 2008; Ihrie and 
Alvarez-Buylla, 2011). Conceivably, LRP2 on ependymal cells may regulate SHH 
levels in the SVZ enabling SHH-dependent neurogenesis to proceed in this stem cell 
niche. 
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  LRP2 has also been genetically associated with autism spectrum 
disorders in several patient cohorts (Ionita-Laza et al., 2012). Although hypothetical at 
present, this activity may also involve a role in control of SHH signaling as defects in 
this morphogen pathway have been implicated in developmental disturbances and in 
impaired neuroprotective mechanisms in autism (Lee and Tierney, 2011; Al-Ayadhi, 
2012). 
 
LRP2 regulates distinct steps of SHH function during eye development 
DBS patients exhibit multiple pathologies including enlarged eyes (buphthalmos) and 
extreme nearsightedness (high myopia). Massive overgrowth of the eye globe is also 
seen in mice (Cases et al., 2015) and zebrafish (Veth et al., 2011) lacking this 
receptor. At first, implicating the loss of LRP2 as an auxiliary SHH receptor in these 
phenotypes seemed counterintuitive as holoprosencephalic phenotypes are typically 
not associated with enlarged and exophthalmic eyes. A possible resolution of this 
mystery came with a new study that substantiated the role of LRP2 as SHH binding 
protein in the retina. However, in this tissue, the receptor acts as an antagonist rather 
than an agonist of the morphogen pathway (Christ et al., 2015). 
 In the developing mammalian eye, SHH is produced by retinal 
ganglion cells. It provides inductive signals to retinal progenitor cells, resulting in 
patterning of the retina in a central to peripheral direction (Wang et al., 2002) (Fig. 
3C). Intriguingly, SHH activity is absent from the distal margin of the developing 
retina, the ciliary marginal zone (CMZ), resulting in quiescence of progenitor cells in 
this tissue (Zhao et al., 2002; Cho and Cepko, 2006). By contrast, in non-mammalian 
species, such as amphibians and fish, the retinal margin constitutes a stem cell niche 
exhibiting proliferative capacity throughout adult life (Lamba et al., 2008). What 
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mechanism causes absence of SHH from the CMZ and why this tissue has to stay 
quiescent in the mammalian eye remains enigmatic. Recent studies now document 
that LRP2 is specifically expressed in the CMZ of the mammalian retina where it may 
act as a clearance receptor for SHH. In this model, LRP2-mediated uptake and 
lysosomal catabolism prevents spread of SHH activity from the central retina into the 
retinal margin and protects progenitor cells in this niche from adverse mitogenic 
stimuli (Fig. 3D). Loss of this “morphogen sink” in the LRP2 mutant retina increases 
the active concentration of SHH in the CMZ, resulting in aberrant expansion of the 
retinal progenitor cell pool and in hyperproliferation of the retinal margin. Enhanced 
retinal progenitor cell proliferation as a consequence of increased SHH signaling is 
also seen in mice heterozygous for the Ptch1 gene defect (Moshiri and Reh, 2004) or 
in animals lacking SUFU, an inhibitor of the SHH pathway (Cwinn et al., 2011), 
supporting this concept. Although not proven formally yet, hyperproliferation of the 
embryonic CMZ possibly contributes to the increase in postnatal eye size in Lrp2-/- 
mice (and DBS patients), as mice with conditional Lrp2 inactivation in the adult lack 
such eye pathologies (Storm et al., 2014). Of note, the ability to act as an inhibitor of 
HH signaling during eye development has also been shown for CDON in zebrafish 
(Cardozo et al., 2014). Clearly, the exact mode of LRP2 action in the retinal margin 
still awaits further experimental consolidation (Fig. 3D). For example, what 
mechanism may prevent LRP2-mediated endocytosis of PTCH1 in the CMZ (but not 
in the RDVM) in the presence of SHH remains unclear. Conceptually, the cell-type 
specific interaction of LRP2 and PTCH1 (or the lack thereof) may be determined by 
the existence of additional interactors that facilitate or prevent co-receptor interaction. 
Such a mechanism is operable in the WNT pathway with transmembrane proteins 
Kremen 1 and 2 blocking LRP5/6 interaction with Frizzled (Mao et al., 2002). 
	   14	  
 The ability to sort SHH into recycling versus degradation fates 
potentially determines the action of LRP2 as agonist or antagonist of the SHH 
pathway. A third possibility how LRP2 may control SHH action entails sorting of the 
morphogen into vesicles destined for transcytosis. During eye formation, SHH also 
acts as a chemoattractant guiding the migration of oligodendrocyte precursor cells 
from the preoptic area to the optic nerve where they differentiate into myelin-
producing oligodendrocytes (Fig. 3E). LRP2 contributes to the formation of such 
SHH guidance cues because the receptor, expressed on optic nerve astrocytes, 
captures locally produced SHH and presents it to oligodendrocyte precursor cells (Fig. 
3F). In line with this activity, blockade of LRP2 activity by inhibitory antibodies 
partially abolishes chemoattraction of oligodendrocyte precursor cells in optic nerve 
explants (Ortega et al., 2012). An effect on SHH-dependent guidance processes 
during eye development is not unique to LRP2 as BOC has been shown to restrict the 
number of retinal ganglion cells that project their axons across the optic chiasm 
(contralateral projections). This activity of BOC encompasses its ability to drive the 
formation of ipsilateral projecting retinal ganglion cells (Sanchez-Arrones et al., 
2013) and to cause SHH-induced repulsion of axonal projection across the optic 
chiasm (Fabre et al., 2010).  
 
Emerging functions for LRP2 in SHH action 
During mammalian heart development, two specific tissues, the anterior heart field 
and the cardiac neural crest, contribute to the formation of the septum that divides the 
cardiac outflow tract into pulmonary artery and aorta. In approximately 2% of 
congenital heart conditions in humans, this truncus arteriosus fails to separate 
properly. As a consequence, a common arterial trunk (CAT) arises from the left and 
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right ventricles and a mixture of oxygenated and deoxygenated blood enters the 
circulatory system. CAT patients suffer from cyanosis (poor oxygen saturation) and 
possible heart failure. SHH is crucial for proper outflow tract formation as Shh-/- mice 
exhibit a single outflow tract (Washington Smoak et al., 2005). Specifically, SHH 
determines the ability of cardiac neural crest cells to populate the outflow tract 
cushions, and it enables myocardial cells to complete septation following cushion 
formation (Goddeeris et al., 2007). In a recessive genetic screen, mutations in Lrp2 
were identified as a novel cause of outflow tract septation defects in mice, implicating 
this receptor in SHH function in the embryonic heart (Li et al., 2015). Mice having 
combined defects in Gas1 and Shh (Martinelli and Fan, 2007), or in Gas1, Cdon, and 
Boc (Allen et al., 2011) suffer from heart looping defects, a phenotype also seen in 
Smo deficient animals (Zhang et al., 2001). Jointly, the above findings underscore the 
relevance of members of the HH receptorsome for multiple steps of heart 
morphogenesis. 
  As well as in embryonic development, recent studies also implicate 
HH binding proteins in pathway activities in the adult organism, most notably in 
tumor formation. Aberrant SHH signaling is causally involved in tumorigenesis in a 
number of tissues, foremost in cerebellum and skin, but also in prostate, bladder, and 
pancreas (reviewed in (Ruiz i Altaba et al., 2002; Rubin and de Sauvage, 2006)). 
Thus, pharmacological intervention with this pathway has proven successful in the 
therapy of basal cell carcinoma of the skin (Von Hoff et al., 2009). The ability of 
SHH to maintain the proliferative capacity of progenitor cell populations infers its 
tumorigenic potential in case of constitute activation of the pathway in adult tissues. 
For example, constitutive pathway activation is seen with activating mutations in 
SMO (Xie et al., 1998) or inactivation mutations in PTCH1 (Hahn et al., 1996; 
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Johnson et al., 1996) in patients with basal cell carcinoma. Also, inappropriate GLI1 
target gene expression causes the uncontrolled proliferation of granule neuron 
precursor cells in medulloblastoma, a malignant tumor of the cerebellum (Lee et al., 
2010). Concerning involvement of HH binding proteins in tumor formation, increased 
levels of BOC are detected in medulloblastoma tissue in patients and mouse models, 
and inactivation of the encoding gene in mice reduces tumor burden (Mille et al., 
2014). Along the same lines, low expression levels of GAS1 correlate with poor 
prognosis in colorectal cancer (Jiang et al., 2011), while inactivation of Cdon 
promotes tumor formation in an experimental model of intestinal cancer in mice 
(Delloye-Bourgeois et al., 2013). At present, the involvement of LRP2 in SHH-
dependent tumorigenesis is speculative, but LRP2 polymorphisms are associated with 
the risk and poor prognosis of cancers of prostate and pancreas (Holt et al., 2008; 
Jones et al., 2008). 
 
Outlook 
Much has been learned about LRP2 as an auxiliary receptor to PTCH1 in SHH signal 
trasnduction, a function that parallels the established role of the related receptors 
LRP5 and LRP6 as co-receptors to Frizzled in WNT signaling (reviewed in (Niehrs 
and Shen, 2010)). It is noteworthy that LRP2 has also been shown to bind and 
mediate the endocytic clearance of bone morphogenetic proteins (Spoelgen et al., 
2005). Thus, an exciting topic to be address in the future may be the potential of 
LRP2 to engage different types of morphogens and to act as convergence point for the 
integration of multiple morphogen pathways in target cells. Also, while a role of 
LRP2 in SHH signaling in the mammalian organism unfolds, the relevance of this 
receptor for HH signaling in non-mammalian species remains an unanswered 
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question. Thus, LRP2 is expressed in organisms as primitive as C. elegans (where the 
receptor is called LRP-1) (Yochem and Greenwald, 1993). Although the existence of 
the HH signaling pathway in nematodes is still a matter of debate, inactivation of the 
hedgehog-related gene qua-1 (Hao et al., 2006) and of lrp-1 (Yochem et al., 1999) 
causes similar larval molting defects. Disruption of mgl, the gene encoding LRP2 in 
Drosophila, results in lethality of fly larvae (Riedel et al., 2011). The underlying 
mode of receptor action in the fruit fly remains enigmatic. However, disruption of 
lrp2 in the zebrafish mutant bugeye causes massive enlargement of the eye globe, a 
phenotype that might be influenced by altered HH signaling in the mutant fish eye 
(Veth et al., 2011). Elucidating the molecular mechanisms of LRP2 action in various 
species will be important to dissect conserved versus newly acquired functions for this 
receptor in the mammalian organism.   
 For reasons of focus, this review has concentrated on the role of LRP2 
in SHH signaling. Obviously, a large body of exciting work, not covered here, has 
identified key contributions of BOC, CDON, and GAS1 to morphogen action in 
vertebrate and non-vertebrate species. Intriguingly, these various HH co-receptors do 
not act autonomously but functionally interact in control of morphogen signaling. 
Dependent on the physiological context, these interactions may be redundant, 
synergistic, or even opposing. This notion is exemplified by the progressive 
worsening of craniofacial malformations in mice with combined receptor deficiencies 
(Allen et al., 2007; Izzi et al., 2011; Zhang et al., 2011), or by the observation that loss 
of Gas1 and Boc promotes whereas the combined loss of Gas1, Boc, and Cdon 
abrogates pancreatic cancer progression (Mathew et al., 2014). In this respect, 
clarifying the genetic interaction of Lrp2 with other members of the HH 
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receptorsome, as in new mouse models with combined receptor gene defects is clearly 
warranted. 
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Text box 1: Cellular SHH signal transduction 
Common to all phyla, the HH pathway in cells is repressed through a cascade of 
inhibitory interactions that are relieved in the presence of the morphogen.	  In brief, 
binding of HH to the 12-pass transmembrane protein Patched 1 (PTCH1) on the 
surface of target cells alleviates its inhibitory effect on the 7-pass transmembrane 
protein Smoothened (SMO). Activated SMO triggers the conversion of the full-length 
form of the glioma-associated (GLI) family of transcription factors into their active 
form, resulting in induction of target gene transcription (reviewed in (Goetz and 
Anderson, 2010; Briscoe and Therond, 2013)). Unique to vertebrates, the activity of 
the HH pathway is intimately linked to a cellular organelle, called the primary cilium 
(Huangfu et al., 2003). Primary cilia are solitary antenna-like structures consisting of 
a basal body, a transition zone, and a filamentous axoneme (see figure). The basal 
body is composed of nine microtubuli triplets that, at the level of the transition zone, 
turn into the doublet microtubuli structure of the axoneme. The transition zone 
(containing transition fibers, Y-linkers, and septins) acts as a selective barrier between 
the cytoplasm and the microenvironment of the axoneme. In contrast to motile cilia, 
arranged in nine microtubuli doublets with an inner microtubule pair (9+2), the 
axoneme of a primary cilium lacks the inner microtubule pair (9+0) and shows no 
motility. The plasma membrane at the base of the primary cilium forms the ciliary 
pocket, a membrane invagination with high endocytic activity and enriched in PTCH1 
molecules. Components of the SHH pathway including PTCH1, SMO, and GLI 
proteins display dynamic movements along the basal body and the ciliary axoneme 
with their specific localization depending on the state of activation of the canonical 
SHH pathway (Corbit et al., 2005; Rohatgi et al., 2007). In the absence of SHH 
(repressed state), PTCH1 localizes to the ciliary base and the axoneme, preventing 
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entry of SMO into the cilium. Because of the absence of activated SMO, full-length 
GLI (GLIFL) fails to accumulate inside the cilium. Although low amounts are still 
found within the axoneme, most GLIFL molecules are subject to phosphorylation by 
protein kinase A (PKA) at the ciliary base (Tuson et al., 2011). Phosphorylated 
GLIFL is targeted for proteolytic processing by the proteasome, generating the 
repressor form of the transcription factors (GLIR) (Wang et al., 2000). The most 
prominent repressor form is GLI3R that translocates to the nucleus and inhibits target 
gene transcription. Repression of the SHH pathway is facilitated by two additional 
factors, SUFU (Suppressor of fused) and KIF7. Binding of SUFU prevents conversion 
of GLIFL into the transcriptional activator form (GLIA), while the kinesin-4 family 
protein KIF7 promotes GLI3R formation. Binding of SHH to PTCH1 results in de-
repression of the pathway (activated), induced by internalization and lysosomal 
degradation of PTCH1/SHH complexes (Incardona et al., 2000). Depletion of PTCH1 
from the cell surface enables SMO to enter the cilium, either via lateral transport from 
the plasma membrane or from an intracellular vesicle pool (Milenkovic et al., 2009; 
Wang et al., 2009). SMO binds to the ciliary proteins EVC (Ellis-van Creveld 
syndrome protein) and EVC2 in a region of the cilium just above the transition zone, 
inducing conformational changes to SMO that cause inhibition of phosphorylation of 
GLIFL by PKA (Dorn et al., 2012). Also upon pathway activation, KIF7 translocates 
into the cilium to promote GLIFL accumulation in the tip of the cilium. In addition, 
KIF7 inhibits SUFU and enables activated GLIA (mainly GLI2A) to move to the 
nucleus where it activates target gene transcription. Anterograde transport of HH 
pathway components to the ciliary tip is performed by the intraflagellar transport 
(IFT)-B complex and the kinesin-2 motor, while their retrograde transport is arranged 
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by dynein motor proteins and the IFT-A complex (Haycraft et al., 2005; Tran et al., 
2008). 	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Text box 2: The LDL receptor gene family 
The LDL receptor gene family encompasses a group of type-1 transmembrane 
proteins that share structural similarity with the LDL receptor, the main receptor for 
uptake of lipoproteins in vertebrate cell types (reviewed in (Dieckmann et al., 2010; 
Willnow et al., 2012)). The figure depicts the mammalian members of this gene 
family. Their extracellular domains contain clusters of complement-type repeats (the 
sites for ligand binding) as well as β-propellers (for pH-dependent release of such 
ligands in endosomes). Similar to the LDL receptor, most LDL receptor-related 
proteins (LRPs) act as clearance receptors internalizing a multitude of ligands, from 
lipoproteins to vitamin carriers to signaling molecules. The LDL receptor is 
dispensable for embryogenesis as judged by the normal development of humans or 
animal models lacking this receptor (Goldstein et al., 2001). By contrast, most LRPs 
are required for embryogenesis and are the cause of congenital defects in humans 
when being mutated. Commonly, LRPs act as co-receptors to signaling proteins, 
modulating ligand binding and/or cellular signal transduction (reviewed in (Willnow 
et al., 2012)). This concept has best been elucidated for LRP5 and LRP6, co-receptors 
to Frizzled in WNT signaling. Lrp6 mutations in mice result in axial truncation and 
abnormal head and limb structures (Pinson et al., 2000), whereas LRP5 mutations 
cause bone formation defects in humans and mouse models (Gong et al., 2001; Kato 
et al., 2002; Little et al., 2002). The role of LRP2 as a co-receptor to PTCH1 in SHH 
signaling is detailed in the main text.  
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FIGURE LEGENDS 
 
Fig. 1: The HH receptorsome 
This scheme depicts the structural organization of PTCH1 and PTCH2 and of HH 
binding proteins identified in mammals. Known interaction sites for HH (asterisk) and 
PTCH1 (star) in the receptors are indicated. 
 
Fig. 2: Cellular fate of ligands internalized by LRP2 
Endocytosis starts with an extracellular ligand binding to LRP2 at the apical cell 
surface of epithelial cells. Receptor/cargo complexes are internalized from the plasma 
membrane and delivered to early endosomes. A drop in luminal pH in early 
endosomes disrupts binding of most ligands to LRP2, enabling the unliganded 
receptor to recycle back to the cell surface while the ligand moves through the late 
endosomal compartments to lysosomes for catabolism. However, some ligand/LRP2 
complexes resist the low pH in early endosomes and recycle back to the cell surface, 
causing re-secretion of the ligand. A third route involves trafficking of receptor cargo 
from early endosomes to the basolateral cell membrane, resulting in transcytosis of 
such ligands. Cytosolic adaptors binding to the cytoplasmic domain of LRP2 to 
promote (+) or inhibit (-) distinct steps in receptor sorting are indicated. AP2, adaptor 
related protein complex 2; ARH, autosomal recessive hypercholesterolemia; DAB2, 
Disabled homolog 2; GIPC, PDZ domain containing family member 1. 
 
Fig. 3: Proposed mechanisms for LRP2-mediated control of SHH trafficking and 
signaling 
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(A-B) LRP2 promotes SHH signaling during forebrain patterning. (A) At neurulation, 
SHH, produced by the prechordal plate (PrCP) acts on the overlying neuroepithelium 
to pattern the rostral diencephalon ventral midline (RDVM), a major forebrain 
organizer region. LRP2 is expressed in the apical surface of the RDVM (green line). 
(B) On the apical surface of neuroepithelial cells, SHH is sequestered by a co-receptor 
complex of LRP2 and PTCH1. SHH binding induces uptake of receptor-ligand 
complexes, lifting PTCH1-dependent suppression of SMO activity. Internalized 
PTCH1 is subject to lysosomal catabolism while SHH is potentially delivered to the 
cellular recycling pathway to increase local morphogen concentration in the RDVM. 
(C-D) LRP2 antagonizes SHH signaling in the developing retina. (C) SHH, produced 
by retinal ganglion cells patterns the developing retina in a central to peripheral 
direction. SHH activity is absent from the ciliary marginal zone (CMZ). LRP2 
expression in the retina is restricted to non-pigmented ciliary epithelial cells in the 
CMZ (green line). (D) Binding of SHH to LRP2 on non-pigmented ciliary epithelial 
cells results in cellular uptake and lysosomal degradation of the morphogen. As a 
consequence of absent SHH ligand, PTCH1 inhibits SMO activity in the CMZ. (E-F) 
LRP2 facilitates SHH action in the developing optic nerve. (E) During optic nerve 
formation, SHH, produced by retinal ganglion cells in the retina, acts as a 
chemoattractant for oligodendrocyte precursor cells (OPC) that migrate from the 
preoptic area to the optic nerve and differentiate into myelin-forming 
oligodendrocytes. LRP2 is expressed on astrocytes in the optic nerve (green line). (F) 
In astrocytes, LRP2 possibly mediates transcytosis of SHH from the apical to the 
basolateral site of the cells, delivering SHH molecules to OPC that respond to the 
morphogen signal with SMO activation. 
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